Chapter title |
Epigenetics in Hematological Malignancies
|
---|---|
Chapter number | 5 |
Book title |
Cancer Epigenetics for Precision Medicine
|
Published in |
Methods in molecular biology, September 2018
|
DOI | 10.1007/978-1-4939-8751-1_5 |
Pubmed ID | |
Book ISBNs |
978-1-4939-8750-4, 978-1-4939-8751-1
|
Authors |
Nataly Cruz-Rodriguez, Alba L. Combita, Jovanny Zabaleta |
Abstract |
Acute leukemias are hematologic malignancies with aggressive behavior especially in adult population. With the introduction of new gene expression and sequencing technologies there have been advances in the knowledge of the genetic landscape of acute leukemias. A more detailed analysis allows for the identification of additional alterations in epigenetic regulators that have a profound impact in cellular biology without changes in DNA sequence. These epigenetic alterations disturb the physiological balance between gene activation and gene repression and contribute to aberrant gene expression, contributing significantly to the leukemic pathogenesis and maintenance. We review epigenetic changes in acute leukemia in relation to what is known about their mechanism of action, their prognostic role and their potential use as therapeutic targets, with important implications for precision medicine. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 5 | 14% |
Student > Bachelor | 4 | 11% |
Professor > Associate Professor | 3 | 8% |
Researcher | 2 | 6% |
Student > Ph. D. Student | 2 | 6% |
Other | 3 | 8% |
Unknown | 17 | 47% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 7 | 19% |
Medicine and Dentistry | 3 | 8% |
Chemistry | 2 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Unspecified | 1 | 3% |
Other | 4 | 11% |
Unknown | 18 | 50% |